NDA 019316 · Fresenius Kabi USA
Magnesium Sulfate
Magnesium Sulfate · Intramuscular, Intravenous
Last checked: Nov 20, 2026Latest source record: Mar 5, 2018 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1986
Sep 8, 1986
Approved uses
1
Original approval plus efficacy supplements
Registered trials
561
123 Phase 3, 51 recruiting
FAERS reports
13,039
11,779 serious, 2,148 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Nov 2, 2026.
INDICATIONS AND USAGE Magnesium Sulfate Injection, USP is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia. In such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 mEq/L) and the serum calcium level is normal (4.3 to 5.2 mEq/L) or elevated. In total parental nutrition (TPN), magnesium sulfate may be added to the nutriend admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. Magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Sep 8, 1986 Original approval · Type 5 - New Formulation or New Manufacturer
4 products under this application
- MAGNESIUM SULFATE · MAGNESIUM SULFATE 10GM/20ML (500MG/ML) · SOLUTION, INTRAMUSCULAR, INTRAVENOUS · Prescription · TE AP
- MAGNESIUM SULFATE · MAGNESIUM SULFATE 5GM/10ML (500MG/ML) · SOLUTION, INTRAMUSCULAR, INTRAVENOUS · Prescription · TE AP
- MAGNESIUM SULFATE · MAGNESIUM SULFATE 25GM/50ML (500MG/ML) · SOLUTION, INTRAMUSCULAR, INTRAVENOUS · Prescription · TE AP
- MAGNESIUM SULFATE · MAGNESIUM SULFATE 1GM/2ML (500MG/ML) · SOLUTION, INTRAMUSCULAR, INTRAVENOUS · Prescription · TE AP
Clinical trials
Interventional ClinicalTrials.gov studies with "Magnesium Sulfate" as an intervention, any sponsor and status, largest first.
- Community Level Interventions for Pre-eclampsiaPivotal-lookingCompleted
University of British ColumbiaAcademic, hospital or other
NCT01911494 · 87,500 participants (planned) · Start Sep 2013 · Primary completion May 2018
Drug: Magnesium Sulfate; Methyldopa · For: Pre-eclampsia; Hypertension, Pregnancy Induced
Sites: Belagavi, India; Maputo, Mozambique; Sagamu, Nigeria · 4 sites in all
- Effect of Protocolized Magnesium Replacement on Mortality and Atrial Fibrillation in Critically Ill PatientsPivotal-lookingRecruiting
Scarborough General HospitalAcademic, hospital or other
NCT07173855 · 3,853 participants (planned) · Start Nov 25, 2025 · Primary completion Mar 1, 2027
Drug: Magnesium sulfate administration; Magnesium oxide and 1 more · For: Critical Illness
Sites: Ajax, Canada; Bowmanville, Canada; Oshawa, Canada · 6 sites in all
- Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)Pivotal-lookingCompleted
The George Washington University Biostatistics CenterAcademic, hospital or other
NCT00014989 · 2,136 participants · Start Dec 1997 · Primary completion Feb 2007
Drug: magnesium sulfate · For: Cerebral Palsy; Intraventricular Hemorrhage; Periventricular Leukomalacia and 2 more
Sites: Birmingham, Alabama; Miami, Florida; Chicago, Illinois · 17 sites in all
- Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe PreeclampsiaPivotal-lookingCompleted
FDA Office of Orphan Products DevelopmentFederal agency
NCT00004399 · 2,000 participants · Start Sep 1995
Drug: magnesium sulfate; nimodipine · For: Pre-eclampsia
- Effectiveness of Calcium Channel Blockade for OP and Carbamate Pesticide PoisoningPivotal-lookingCompleted
University of EdinburghAcademic, hospital or other
NCT03925025 · 1,728 participants · Start Jun 11, 2020 · Primary completion Mar 31, 2025
Drug: Magnesium Sulfate; Nimodipine · For: Anticholinesterase Insecticide Poisoning; Pesticide Poisoning
Sites: Rajshahi, Bangladesh; Bogura, Bangladesh; Chittagong, Bangladesh · 7 sites in all
- Field Administration of Stroke Therapy - Magnesium (FAST-MAG) TrialPivotal-lookingCompleted
Jeffrey L. SaverAcademic, hospital or other
NCT00059332 · 1,700 participants · Start Jan 2005 · Primary completion Mar 2013
Drug: Magnesium Sulfate; Normal Saline · For: Cerebrovascular Accident
Sites: Los Angeles, California
- Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, UgandaPivotal-lookingStatus unknown
MRC/UVRI and LSHTM Uganda Research UnitAcademic, hospital or other
NCT00674921 · 1,650 participants (planned) · Start Jun 2008 · Primary completion Jun 2011
Drug: cotrimoxazole; Placebo · For: HIV Infections
Sites: Entebbe, Uganda
- Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old InfantsPivotal-lookingCompleted
Sinovac Biotech Co., LtdIndustry
NCT05386810 · 1,572 participants · Start Nov 5, 2020 · Primary completion Oct 8, 2022
Drug: Experimental vaccine; IPV control vaccine and 1 more · For: Poliomyelitis
Sites: Kaifeng, China; Xuchang, China
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- drug ineffective1,204
- nausea854
- off label use846
- pyrexia802
- maternal exposure during pregnancy772
- foetal exposure during pregnancy705
- pain705
- premature baby686
- diarrhoea646
- dyspnoea607
- hypotension575
- anaemia565
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 145 |
| 2005 | 160 |
| 2006 | 199 |
| 2007 | 417 |
| 2008 | 383 |
| 2009 | 481 |
| 2010 | 249 |
| 2011 | 653 |
| 2012 | 586 |
| 2013 | 259 |
| 2014 | 375 |
| 2015 | 361 |
| 2016 | 487 |
| 2017 | 563 |
| 2018 | 640 |
| 2019 | 688 |
| 2020 | 950 |
| 2021 | 1,075 |
| 2022 | 1,096 |
| 2023 | 1,031 |
| 2024 | 863 |
| 2025 | 800 |
| 2026 | 577 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Part D: Magnesium Sulfate (Magnesium Sulfate)
2024 spending
$174K
Beneficiaries
1,025
9,530 claims
Per beneficiary
$170
$0.15 per unit
View as table
| Year | Spending |
|---|---|
| 2020 | $151,932 |
| 2021 | $173,602 |
| 2022 | $134,834 |
| 2023 | $169,024 |
| 2024 | $173,951 |
Part D: Magnesium Sulfate (Magnesium Sulfate In Water)
2024 spending
$34K
Beneficiaries
229
848 claims
Per beneficiary
$148
$0.18 per unit
View as table
| Year | Spending |
|---|---|
| 2020 | $13,826 |
| 2021 | $20,802 |
| 2022 | $27,166 |
| 2023 | $20,086 |
| 2024 | $33,858 |
Part B: Magnesium Sulfate* (Magnesium Sulfate*) · HCPCS J3475
2024 spending
$256K
Beneficiaries
19,942
114,020 claims
Per beneficiary
$13
2024 ASP limit $0.58 per unit
View as table
| Year | Spending |
|---|---|
| 2020 | $301,130 |
| 2021 | $370,548 |
| 2022 | $331,697 |
| 2023 | $350,744 |
| 2024 | $256,083 |
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Intravenous magnesium sulfate for asthma exacerbations in children: Systematic review with meta-analysis.
Ambrożej D, Adamiec A, Forno E, et al. · Paediatr Respir Rev 2024 · Meta-Analysis, Systematic Review
- Role of nebulised magnesium sulfate in treating acute asthma in children: a systematic review and meta-analysis.
Kumar J, Kumar P, Goyal JP, et al. · BMJ Paediatr Open 2024 · Systematic Review, Meta-Analysis
- The effects of intraoperative magnesium sulfate administration on emergence agitation and delirium in pediatric patients: A systematic review and meta-analysis of randomized controlled trials.
Koo CH, Koo BW, Han J, et al. · Paediatr Anaesth 2022 · Meta-Analysis, Systematic Review
- Laxatives after hemorrhoidectomy.
Johnson CD, Budd J, Ward AJ · Dis Colon Rectum 1987 · Clinical Trial, Comparative Study
- Intravenous Bronchodilators in Pediatric Critical Asthma: A Systematic Review and Network Meta-Analysis.
Abu-Sultaneh S, Miller AG, Basnet S, et al. · Pediatr Pulmonol 2025 · Systematic Review, Network Meta-Analysis
- Antenatal Magnesium Sulfate and adverse gastrointestinal outcomes in Preterm infants-a systematic review and meta-analysis.
Prasath A, Aronoff N, Chandrasekharan P, et al. · J Perinatol 2023 · Meta-Analysis, Systematic Review
Sponsor: Fresenius Kabi USA
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.